Table 2.
Risk of anastomotic leak controlling for the competing risk of death, clustered at the institutional level
| Multivariate analysis A | Multivariate analysis Ba | |||||
|---|---|---|---|---|---|---|
| SHR | 95% CI | p-value | SHR | 95% CI | p-value | |
| DLI (ref = no DLI) | 0.42 | 0.27–0.65 | < 0.001 | 0.36 | 0.23–0.57 | < 0.001 |
| Age | 1.0–0 | 0.98–1.02 | 0.73 | 0.98 | 0.98–1.02 | 0.85 |
| Male sex (ref = female sex) | 2.59 | 1.70–3.95 | < 0.001 | 1.43 | 1.43–3.81 | 0.001 |
| Weight loss (ref = no preoperative weight loss) | 0.88 | 0.88–2.95 | 0.12 | |||
| Neoadjuvant CRT (ref = no neoadjuvant CRT) | 0.67 | 0.67–2.44 | 0.45 | |||
| Active smoking (ref = non-smokers) | 0.46 | 0.46–2.78 | 0.80 | |||
Bolded values indicate statistical significance
DLI diverting loop ileostomy, SHR subhazard ratio, CI confidence interval, CRT chemoradiation, ref reference
aGiven the limited number of AL events, Fine-Gray models were created with a limited number of variables that were significant on univariate analysis to avoid overfitting (analysis A). A second analysis (analysis B) included a greater number of clinically relevant variables